Clinical Trials on Malignant Neoplasms of Urinary Tract in Japan
Total 1509 results
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Gilead SciencesTerminatedAcute Myeloid Leukemia | Hematologic MalignancyJapan
-
TakedaRecruitingNon-small Cell Lung Cancer (NSCLC)Japan
-
Wakayama Medical UniversityMerck Sharp & Dohme LLCUnknownSmall Cell Lung Cancer Extensive StageJapan
-
Kyowa Kirin Co., Ltd.CompletedAdvanced/Recurrent Non-small-cell Lung CancerJapan
-
Kyoto UniversityCompletedSexual Dysfunction, Physiological | Colorectal Surgery | Surgery, LaparoscopicJapan
-
Hamamatsu UniversityCompletedNon-Small Cell Lung CancerJapan
-
Translational Research Center for Medical Innovation...Kagawa UniversityCompleted
-
Fuji Yakuhin Co., Ltd.CompletedHealthy | Renal InsufficiencyJapan
-
Taewoong Medical Co., Ltd.CompletedPancreatic Cancer | Cancer of Bile DuctKorea, Republic of, Japan
-
Merck KGaA, Darmstadt, GermanyMerck Serono Co., Ltd., JapanCompletedInfertility | Ovulation InductionJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-Small Cell Lung CancerJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedSmall Cell Lung CancerJapan
-
HutchmedActive, not recruitingNeuroendocrine Tumors | Non-hematologic MalignancyJapan
-
Chiba UniversityCompleted
-
PfizerTerminatedNeoplasms MalignantUnited States, Korea, Republic of, Japan, China, Taiwan, Italy, Russian Federation
-
Astellas Pharma IncCompletedSecondary HyperparathyroidismJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Osaka General Medical CenterCompletedEmergent Coronary ProcedureJapan
-
Astellas Pharma IncCompleted
-
EPS CorporationCompleted
-
Mitsubishi Tanabe Pharma AmericaCompletedHealthy | Renal ImpairmentJapan
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; University... and other collaboratorsRecruitingBladder CancerUnited States, Japan
-
Akita University HospitalHuman Genome Center, Institute of Medical Science, University of TokyoSuspendedBile Duct CancerJapan
-
PfizerCompletedCarcinoma, Non-Small-Cell LungJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityCompletedNon-small Cell Lung CancerJapan
-
Astellas Pharma IncCompleted
-
Tokyo Women's Medical UniversityTokyo Metropolitan Bokuto HospitalCompleted
-
junya mitaCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Kissei Pharmaceutical Co., Ltd.WithdrawnOveractive BladderJapan
-
Astellas Pharma IncCompleted
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study GroupActive, not recruitingNon-squamous Non-small-cell Lung Cancer | Cancer, LungJapan
-
Kobe City General HospitalTerminatedAdvanced Non-small Cell Lung CancerJapan
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerJapan
-
Boehringer IngelheimTerminated
-
Kyoto UniversityWithdrawnLocalized Resectable Adult Primary Liver Cancer | Stage III Childhood Liver CancerJapan
-
Kyowa Kirin Co., Ltd.Completed
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon Small Cell Lung CancerJapan
-
Chiba UniversityCompletedPancreatic Cancer | Bile Duct CancerJapan
-
CelgeneRecruiting
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Cell Carcinoma of the Head and NeckJapan
-
Ferring PharmaceuticalsCompletedNocturia Due to Nocturnal PolyuriaJapan
-
Novartis PharmaceuticalsRecruitingMesotheliomaAustralia, Switzerland, Italy, Spain, Canada, Germany, Japan, United Kingdom, Netherlands, United States, France